Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Orchid has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Orchid's investors include Village Global, Pebblebed, Day One Ventures, Refactor, Olive Capital.
Orchid is headquartered in San Francisco, United States.
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Orchid is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orchid — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/orchid. Accessed July 19, 2026.
VCBacked. (2023). Orchid — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/orchid
{{cite web |title=Orchid — Funding & Investors |url=https://www.vcbacked.co/company/orchid |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated